Your session is about to expire
← Back to Search
Adenosine for Premature Ventricular Contractions
Study Summary
This trial will study whether a drug called adenosine can help people with a heart condition called PVC. One hundred people will be given adenosine and/or verapamil to see if their arrhythmias can be controlled better.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2011 Phase 3 trial • 22 Patients • NCT03231371Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have asthma and are going to be given adenosine.I have severe narrowing (70% or more) in my heart's arteries.I am between 18 and 70 years old.I understand the study and can agree to participate.I am currently taking medication for heart rhythm problems.I am scheduled for a procedure to correct heart rhythm issues caused by PVCs.I have a heart condition involving the structure of my heart.I have been diagnosed with irregular heartbeats.
- Group 1: Adenosine/ Verapamil Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this clinical trial still recruiting participants?
"Affirmative. Clinicaltrials.gov reveals that this research endeavor, which commenced on February 13th 2017, is actively recruiting participants. Approximately 100 people must be enrolled at a single medical site."
How many participants are taking part in this clinical trial?
"Affirmative, the information hosted on clinicaltrials.gov suggests that this research is actively seeking suitable candidates. This investigation was launched on February 13th 2017 and recently updated in October 17th 2022; 100 individuals are required to be recruited from one medical facility."
Is the treatment being proposed secure for patients?
"We assign this therapy a safety score of 3, as there is ample evidence that it has been approved in Phase 4 clinical trials."
In what cases is this therapy typically implemented?
"This novel intervention offers potential relief for individuals suffering from tachycardia, ventricular issues, vasospastic angina, and difficulty exercising."
Is this research open to elderly participants?
"The requirements for participation in this clinical trial necessitate that applicants must be between 18 and 70 years old. For those younger than eighteen, there are 186 studies available; similarly, 90 research initiatives exist for seniors above the age of 65."
Is there an eligibility criterion for participating in this clinical investigation?
"In order to be considered for the trial, potential patients must have ventricular premature complexes and lie between 18 to 70 years of age. This medical study is set to enroll 100 individuals."
Share this study with friends
Copy Link
Messenger